CWM
GILD icon

Cornerstone Wealth Management’s Gilead Sciences GILD Stock Holding History

Cornerstone Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$918K Sell
7,265
-67
-0.9% -$8.83K 0.04% 353
2026
Q1 		$1.02M Buy
7,332
+238
+3% +$33.3K 0.05% 312
2025
Q4 		$871K Sell
7,094
-385
-5% -$46.8K 0.05% 316
2025
Q3 		$830K Buy
7,479
+113
+2% +$12.8K 0.05% 312
2025
Q2 		$817K Buy
7,366
+10
+0.1% +$1.06K 0.05% 308
2025
Q1 		$824K Sell
7,356
-308
-4% -$31.8K 0.06% 279
2024
Q4 		$708K Buy
7,664
+15
+0.2% +$1.35K 0.05% 294
2024
Q3 		$641K Sell
7,649
-190
-2% -$14.5K 0.05% 301
2024
Q2 		$538K Sell
7,839
-185
-2% -$12.3K 0.04% 320
2024
Q1 		$588K Sell
8,024
-415
-5% -$31.9K 0.05% 304
2023
Q4 		$684K Sell
8,439
-574
-6% -$44.7K 0.06% 256
2023
Q3 		$676K Buy
9,013
+373
+4% +$28.7K 0.06% 246
2023
Q2 		$666K Buy
8,640
+344
+4% +$27.4K 0.06% 252
2023
Q1 		$688K Buy
+8,296
New +$687K 0.07% 233
2022
Q3 		$523K Buy
8,470
+38
+0.5% +$2.4K 0.06% 245
2022
Q2 		$521K Buy
8,432
+285
+3% +$17.6K 0.06% 251
2022
Q1 		$484K Sell
8,147
-713
-8% -$45.6K 0.05% 278
2021
Q4 		$636K Buy
8,860
+29
+0.3% +$2K 0.06% 245
2021
Q3 		$617K Sell
8,831
-649
-7% -$45.6K 0.07% 238
2021
Q2 		$653K Buy
9,480
+539
+6% +$36K 0.07% 248
2021
Q1 		$578K Buy
8,941
+1,703
+24% +$110K 0.07% 251
2020
Q4 		$422K Buy
7,238
+404
+6% +$24.4K 0.05% 275
2020
Q3 		$432K Sell
6,834
-701
-9% -$48.6K 0.06% 241
2020
Q2 		$580K Buy
7,535
+341
+5% +$26.1K 0.09% 193
2020
Q1 		$538K Buy
7,194
+2,883
+67% +$199K 0.1% 189
2019
Q4 		$280K Sell
4,311
-651
-13% -$42.4K 0.05% 279
2019
Q3 		$314K Buy
4,962
+174
+4% +$11.4K 0.06% 261
2019
Q2 		$324K Buy
4,788
+448
+10% +$29.5K 0.06% 264
2019
Q1 		$1.11M Sell
4,340
-77
-2% -$5.12K 0.14% 174
2018
Q4 		$275K Sell
4,417
-408,385
-99% -$28.5M 0.06% 269
2018
Q3 		$5.04M Buy
412,802
+48,753
+13% +$3.68M 0.06% 287
2018
Q2 		$5.11M Buy
364,049
+359,060
+7,197% +$25.4M 0.06% 314
2018
Q1 		$362K Sell
4,989
-599
-11% -$47.6K 0.07% 267
2017
Q4 		$411K Buy
5,588
+553
+11% +$42K 0.08% 255
2017
Q3 		$413K Sell
5,035
-42
-0.8% -$3.21K 0.09% 234
2017
Q2 		$349K Buy
5,077
+814
+19% +$54.2K 0.08% 242
2017
Q1 		$284K Buy
4,263
+1,037
+32% +$72.9K 0.07% 259
2016
Q4 		$238K Buy
3,226
+549
+21% +$40.8K 0.08% 240
2016
Q3 		$207K Buy
+2,677
New +$217K 0.08% 253

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Cornerstone Wealth Management's GILD Position: Q2 2026 in Review

Cornerstone Wealth Management reduced its Gilead Sciences (GILD) stake by 0.91% in Q2 2026, selling an estimated $8.83K and leaving 7,265 shares worth $918K. The position accounts for 0.04% of the portfolio, ranked #353.

Cornerstone Wealth Management first reported a position in GILD in Q3 2016 and has held it in 39 quarters since. The position peaked at $5.11M in Q2 2018. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Cornerstone Wealth Management held 7,265 shares of Gilead Sciences worth $918K as of Q2 2026.
  • Cornerstone Wealth Management sold 67 Gilead Sciences shares in Q2 2026, an estimated $8.83K.
  • Gilead Sciences made up 0.04% of Cornerstone Wealth Management's portfolio in Q2 2026, its #353 holding.
  • Cornerstone Wealth Management first reported a position in Gilead Sciences in Q3 2016 and has held it in 39 quarters since.
  • Cornerstone Wealth Management's Gilead Sciences position peaked at $5.11M in Q2 2018.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Cornerstone Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.